FDA Drug Application (202517) for TELMISARTAN AND AMLODIPINE by TORRENT PHARMS LTD

Back to FDA Applications sponsored by TORRENT PHARMS LTD

Application Number202517
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE;40MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTELMISARTAN AND AMLODIPINE
Active IngredientAMLODIPINE BESYLATE; TELMISARTAN



Back to FDA Applications sponsored by TORRENT PHARMS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.